The Clinical Safety and Pharmacovigilance Certificate Program is designed to develop specialized knowledge and skills required to; write study protocols, monitor and manage clinical trials, and to conduct drug safety and pharmacovigilance activities. This hands-on training approach includes drafting adverse reaction reports and preparing periodic safety update reports.
The program focuses on the global healthcare system as well as the Canadian healthcare system, Canadian regulatory agencies, health care legislation, international guidelines, and standard operating procedures (SOP). Using practical and current real cases, AAPS integrates a unique approach and provides students with the foundation and practical knowledge to formulate a sound clinical development plan; ensure clinical trial data is credible and accurate; and that the rights, integrity and confidentiality of trial subjects are protected.
A well-trained and knowledgeable Clinical Research and Pharmacovigilance professional plays a vital role in protecting the study participant and the general population for marketed drugs and in helping to reduce the time between drug development and marketing approval. The demand for knowledgeable and trained Clinical Research and Pharmacovigilance professionals continues to grow, as supply is limited.
The program focuses on topics delivered through 15 modules:
A well-trained and knowledgeable Drug Safety and Pharmacovigilance professional plays a vital role in protecting the study participant and the general population for marketed drugs and in helping to reduce the time between drug development and marketing approval.
Upon completion, you will receive a Certificate on Drug Safety and Pharmacovigilance that is approved by the Ministry of Colleges and Universities.
Successful candidates will also receive certificates per completed module: